Harvard Bioscience, Inc. (NASDAQ:HBIO) Q2 2024 Earnings Conference Call August 8, 2024 10:00 AM ET

Company Participants

Kathryn Flynn - Corporate Controller
James Green - Chairman, President and CEO
Jennifer Cote - CFO

Conference Call Participants

Paul Knight - KeyBanc Capital Markets
Bruce Jackson - The Benchmark Company
Christopher Sakai - Singular Research

Operator

Good day, and thank you for standing by. Welcome to the Q2 2024 Harvard Bioscience, Inc. Earnings Conference Call. At this time, all participants are in a listen-only mode. Please be advised that today's conference is being recorded. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions].

I would now like to hand the conference over to your speaker today, Kathryn Flynn, Corporate Controller.

Kathryn Flynn

Thank you, Josh, and good morning, everyone. Thank you for joining the Harvard Bioscience second quarter 2024 earnings conference call. Leading the call today will be Jim Green, President and Chief Executive Officer; and Jennifer Cote, Chief Financial Officer. In conjunction with today's recorded call, we have provided a presentation that will be referenced during our remarks that is posted to the Investors section of our website at investor.harvardbioscience.com.

Please note that statements made in today's discussion that are not historical facts, including statements or expectations or future events or future financial performance are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those expressed or implied. Please refer to today's press release for other disclosures on forward-looking statements. These factors and other risks and uncertainties are described in the company's filings with the Securities and Exchange Commission. Harvard Bioscience assumes no obligation to update or revise any forward-looking statements publicly, and management's statements are made as of today.

During the call, management will also reference certain non-GAAP income measures, which can be useful in evaluating the company's operations related to our financial condition and results. These non-GAAP measures are intended to supplement GAAP financial information and should not be considered as a substitute. Reconciliations of GAAP to non-GAAP measures are provided in today's earnings press release.

I will now turn the call over to Jim. Jim, please go ahead.

James Green

Thank you, Kathryn. Hello, everybody. Let's move to Slide 3 of the presentation and look at our quarterly results. We had a tough first half of the year, and Q2 was more challenging than expected. Revenue in the second quarter came in at $23.1 million. That's down $5.7 million from last year.